Clinical Trials
3 trialsNCT01835288 2018-05-21
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Stanford University
Phase 2 Withdrawn
NCT00006092 2012-09-26
Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT00005795 2012-06-11
Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia
Northwestern University
Phase 2 Completed